Close the acquisition of Biosev S.A
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 9 Feb 2021
- Due
- 31 Aug 2021
- Delivered
- 10 Aug 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The Closing of the Transaction is expected to take place in the next 6 months.”
What we found
Evidence strength A What the grades mean
The company confirmed in a 6-K filing that the acquisition of all shares issued by Biosev was concluded on August 10, 2021.
-
A Cosan S.A. 6-K filed 2021-11-15
“On August 10, 2021, the acquisition of all the shares issued by Biosev was concluded.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Biosev S.A. acquisition
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: subject to the satisfaction of certain conditions precedent set forth in the Agreement
- Depends on
- Regulatory, Counterparty
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Cosan S.A.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-CSANY-023318 · Corrections policy